TNFi is associated with decreased risk of COVID-19 related hospitalization: Follow up of “Clinical outcomes of COVID-19 in patients taking tumor necrosis factor inhibitors and methotrexate.”
Published: 27 June 2022| Version 2 | DOI: 10.17632/tvvwmbry4h.2
Contributor:
Rachel TallmanDescription
Supplementary Appendix
Files
Institutions
West Virginia University
Categories
Dermatology